S-EPMC7481636 - Simultaneous targeting of MET overexpression in <i>EGFR</i> mutation-positive non-small cell lung cancer can increase the benefit of EGFR-TKI therapy? - OmicsDI

Unknown

Dataset Information

Simultaneous targeting of MET overexpression in EGFR mutation-positive non-small cell lung cancer can increase the benefit of EGFR-TKI therapy?

ABSTRACT:

SUBMITTER: Kanemura H

PROVIDER: S-EPMC7481636 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature